LoA Update: Merus' zenocutuzumab has a five-point increase in chances for transition to next ...

Retrieved on: 2021-06-11 14:48:45

Tags for this article:

Click the tags to see associated articles and topics

LoA Update: Merus' zenocutuzumab has a five-point increase in chances for transition to next .... View article details on hiswai:

Excerpt

The update occurred on 7 June on the heels of a pooled data analysis from an ongoing trial being presented at the 2021 ASCO Annual Meeting.

Article found on: www.clinicaltrialsarena.com